NCT05654103View on ClinicalTrials.gov

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

January 1, 2028

Conditions
End Stage Renal Disease on Dialysis
Interventions
DEVICE

endoAVF

The device will be used according to manufactures instructions and medical facilities standard of care. EndoAVF has a high likelihood of requiring additional procedures that would not have been required if they had undergone surgAVF.

PROCEDURE

surgAVF

The surgAAVF procedure will be done according to the medical facilities standard of care. SurgAVF can also require additional procedures to help with the fistula being useable.

Trial Locations (2)

15231

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

90095

RECRUITING

UCLA Division of Vascular and Endovascular Surgery Clinic, Los Angeles

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, Los Angeles

OTHER

NCT05654103 - Comparing Surgical and Endovascular Arteriovenous Fistula Creation | Biotech Hunter | Biotech Hunter